Hair regrowth in 2 patients with recalcitrant central centrifugal cicatricial alopecia after use of topical metformin

Erinolaoluwa F Araoye, Jamael A L Thomas, Crystal U Aguh, Erinolaoluwa F Araoye, Jamael A L Thomas, Crystal U Aguh

No abstract available

Keywords: AMPK, adenosine monophosphate-activated protein kinase; CCCA, central centrifugal cicatricial alopecia; FPD, fibroproliferative disorder; ILK, intralesional triamcinolone acetonide; black hair; central centrifugal cicatricial alopecia; ethnic hair; topical therapeutics; treatment.

Figures

Fig 1
Fig 1
Improvement of central centrifugal cicatricial alopecia after application of topical metformin in case 1. A, Central centrifugal cicatricial alopecia in patient 1 before initiation of topical metformin. B, Hair regrowth observed after 6 months of topical 10% metformin treatment.
Fig 2
Fig 2
Improvement of central centrifugal cicatricial alopecia after application of topical metformin in case 2. A, Central centrifugal cicatricial alopecia in patient 2 before initiation of topical metformin. B, Hair regrowth after 4 months of topical 10% metformin treatment.

References

    1. Olsen E.A., Callender V., Sperling L. Central scalp alopecia photographic scale in African American women. Dermatol Ther. 2008;21(4):264–267.
    1. Wynn T.A. Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J Clin Invest. 2007;117(3):524–529.
    1. Rangarajan S., Bone N.B., Zmijewska A.A. Metformin reverses established lung fibrosis in a bleomycin model. Nat Med. 2018;24(8):1121–1127.
    1. Dina Y., Okoye G.A., Aguh C. Association of uterine leiomyomas with central centrifugal cicatricial alopecia. JAMA Dermatol. 2018;154(2):213–214.
    1. Aguh C., Dina Y., Talbot C.C., Garza L. Fibroproliferative genes are preferentially expressed in central centrifugal cicatricial alopecia. J Am Acad Dermatol. 2018;79(5):904–912.e1.
    1. Da Silva Morais A., Abarca-Quinones J., Guigas B. Development of hepatic fibrosis occurs normally in AMPK-deficient mice. Clin Sci. 2009;118(6):411–420.
    1. An H., He L. Current understanding of metformin effect on the control of hyperglycemia in diabetes. J Endocrinol. 2016;228(3):R97–R106.
    1. Markowicz-Piasecka M., Huttunen K.M., Mateusiak L., Mikiciuk-Olasik E., Sikora J. Is metformin a perfect drug? Updates in pharmacokinetics and pharmacodynamics. Curr Pharm Des. 2017;23(17):2532–2550.
    1. González-Saldivar G., Rodríguez-Gutiérrez R., Ocampo-Candiani J., González-González J.G., Gómez-Flores M. Skin manifestations of insulin resistance: From a biochemical stance to a clinical diagnosis and management. Dermatol Ther (Heidelb) 2016;7(1):37–51.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir